Teladoc Health Inc. signs on the floor of the New York Stock Exchange (NYSE) on Tuesday, December 31, 2024.
Michael Nagle | Bloomberg | Getty Images
Teladoc Health The stock traded on Wednesday after the company reported a larger loss than analysts expected. release Disappointing quarterly guidance.
This is the case with the consensus estimates of LSEG analysts.
- Loss per share: 28 cents, estimated 24 cents
- income: $640.5 million, estimated $639.6 million
According to a press release, the telemedicine company’s revenue fell 3% from $660.5 million a year ago. Teladoc’s net loss expanded to $28.9 million a year ago, a loss of 17 cents a share, to 28 cents a share, or 28 cents a share.
Teladoc is in the depths Crushdue to fierce competition in telehealth, stock prices have fallen over the past four years, with better challenges in the mental health sector and high operating costs.
When Teladoc acquired digital health company Livongo in 2020, these companies had one United Enterprises are worth $37 billion. Teladoc has a market capitalization of about $1.9 billion as of Wednesday.
“As we look forward to in 2025, execution will continue to be a top priority as we promote efforts to unlock growth opportunities and position for long-term success,” Teladoc CEO Chuck Divita said in a statement. “We will also continue to focus on our cost structure, which is based on the significant improvements made in 2024 the previous year.”
Teladoc reported adjusted revenue for the fourth quarter of $74.8 million, down 35% from the same period last year. The company’s adjusted earnings in the comprehensive care sector fell 5% to $53.2 million, while BetterHelp’s adjusted earnings fell 63% to $21.7 million.
Teladoc said in the first quarter, revenue was expected to be between $668 million and $629 million, while analysts expected $632.9 million. The company said adjusted earnings ranged from $47 million to $59 million during the period.
Earlier this month, Teladoc Announce It will get preventive health care companies Ejection Health A full-cash deal was reached for $65 million. Teladoc said its outlook includes the expected contribution of the transaction, but does not include potential damage or the impact of purchasing accounting. Teladoc said the acquisition should end at the end of the month.
Teladoc will hold a quarterly call with investors at 4:30 pm ET.
– Bertha Coombs of CNBC contributed to this report.
